John Mendlein
Male, Person
Who is John Mendlein?
Dr. John Mendlein is a biotech executive and formerly CEO of Adnexus Therapeutics, a Boston, MA based biotech company founded by Flagship Ventures and acquired by Bristol-Myers Squibb for over $500M. He was formerly CEO of Affinium Pharmaceuticals. Prior to managing Affinium, Dr. Mendlein was the Chief Knowledge Officer at Aurora Biosciences, a company co-founded by Nobel laureate Roger Y. Tsien and since acquired by Vertex Pharmaceuticals.
Under Dr. Mendlein's leadership, Adnexus was acquired by Bristol-Myers Squibb for roughly US$400M.
After selling and leaving Adnexus, Dr. Meinlein became the Chairman of Fate Therapeutics, a stem cell company. In May 2010, he joined aTyr Pharma as Executive Chairman.
We need you!
Help us build the largest biographies collection on the web!
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"John Mendlein." Biographies.net. STANDS4 LLC, 2024. Web. 7 May 2024. <https://www.biographies.net/people/en/john_mendlein>.
Discuss this John Mendlein biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In